Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
As Kalorama Information's lead diagnostic analyst finds, the point of care concept is at a crossroads: the technologies needed to make rapid testing a reality are here. But is healthcare ready? The drive for wellness and the attention surrounding healthcare reform will surely focus attention on rapid diagnostics. However, according to Shara Rosen, RT, M.B.A., there are many challenges which must be overcome for point of care solutions to fit, and those companies willing to pivot strategies and best adjust to changes in the healthcare marketplace may be rewarded.
This report, Point of Care Diagnostics 2010: Rapid Testing at a Crossroads represents the most current analysis of the role of Point of Care Diagnostics in today's in vitro industry. Other reports have looked at products, companies and market forecasts, as this report does. But in her analysis Shara Rosen takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. The report includes:
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The report offers a quantitative assessment of specific markets in US dollars for 2008 and forecasted out to 2013. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage, the following companies are discussed:
This report, Point of Care Diagnostics 2010: Rapid Testing at a Crossroads represents the most current analysis of the role of Point of Care Diagnostics in today's in vitro industry. Other reports have looked at products, companies and market forecasts, as this report does. But in her analysis Shara Rosen takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. The report includes:
- Markets for POC Diagnostics (Diabetes, Cardiac markers, Clinical Chemistry/Critical Care, Hematology, Coagulation, Drugs of Abuse/Therapeutic Drug Monitoring, Infectious Diseases, Pharmacodiagnostics, Sepsis, Oncology, Women’s health / Pregnancy/Fertility)
- By Venue Revenue Estimates for Hospital POC, Physician POC and Other Venue
- Review of Products in the Market
- Forecasts to 2013
- Markets and Forecasts for Self-Testing (OTC)
- The role of EMR in the Point of Care Market
- Possible Effects of Healthcare Reform
- POLs, Home Monitoring, Alternate Samples and Other Trends
- Successful Strategies of POC Companies
- Profiles of Over 100 Companies Competing in this Market
All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.
The report offers a quantitative assessment of specific markets in US dollars for 2008 and forecasted out to 2013. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.
As part of Kalorama Information's comprehensive coverage, the following companies are discussed:
- 23andMe
- 3M Health Care
- 77 Elektronika
- A. Menarini
- A/C Diagnostics
- Abaxis, Inc.
- Abbott Diagnostics
- ABTECH Scientific
- Accumetrics
- ACIST Medical
- Acrongenomics Inc.
- Adeza Biomedical
- ADIATEC
- Aerscher Diagnostics
- AgaMetrix, Inc.
- Alfa Scientific
- Alfa Wassermann
- Alverix Inc.
- American Bio Medica
- Amic/Ortho
- Amnisure International
- Animas/J&J
- ANP Technologies
- Antigen Discovery Inc.
- Apollo Hospitals
- Arkray
- Arrayit Diagnostics
- AspenBio Pharma
- Astron Clinica
- AT First Diagnostic
- Audit Diagnostics
- Axis-Shield plc
- Bayer Diabetes Care
- Beckman Coulter
- Becton Dickinson
- Bedfont Scientific
- Biohit Oy
- BioIQ
- bioLytical Labs
- Biomagnetics Diagnostics
- Biomerica, Inc.
- bioMérieux
- Bionime Corp.
- Bio-Rad Laboratories
- BIOSAFE Medical Technologies
- Biosite/Inverness
- Boditech Med
- BodyTel Scientific
- Branan Medical Corp
- Burnet Institute
- Calypte Biomedical
- Careside Medical
- Carolina Liquid Chemistries
- Celerus Diagnostics
- Chelsea Technologies
- Chembio Diagnostic
- Chempaq A/S
- Chemtron Biotech
- Cholestech Corp.
- Claros Diagnostics
- CLX Medical, Inc.
- Combimatrix
- Common Sense, Ltd.
- Commonwealth Labs
- Connectyx Technologies
- ContraVac, Inc.
- Decision Biomarkers
- DexCom, Inc.
- Diabetech, LP
- Diabetes Sentry
- Diaglobal GmbH
- Diagnostic Devices
- Diagnostics for All
- Diagnostics for the Real World
- Diazyme Laboratories
- Digital Bio Tech
- Diversa Limited
- DNA Direct, Inc.
- DNAFORM
- DxNA
- Echo Therapeutics
- EKF-diagnostic GmbH
- Enfora
- Enigma Diagnostics
- Enterix Inc.
- Entra Health
- Epocal, Inc.
- EPS Bio Technology
- ESA Biosciences
- eScreen, Inc.
- ExpressMD Solutions
- EyeMarker Systems
- Flexsite Diagnostics
- Focus Diagnostics
- Fora Care
- GE Healthcare
- GenBio
- Gene Smart Wellness
- Genexel-Sein Inc.
- Gentag Inc.
- Genzyme Diagnostics
- Global Detection & Reporting
- Glucometrics, Inc.
- Google, Inc.
- Guided Therapeutics
- Hai Kang Life Corp.
- Hain Lifescience GmbH
- HandyLab, Inc.
- HealthPia America
- HealthPort
- Helena Laboratories
- Hema Diagnostic Systems
- Hema Metrics
- HemoCue AB
- Hero Network Network
- HMM GmbH
- Hoana Medical
- Home Access Health
- Home Diagnostics
- Horiba ABX
- Idaho Technology
- IDenta Corp
- Identigene
- IDEXX Laboratories
- incentaHEALTH LLC
- Innovative Biosensors
- Instrumentation Laboratory
- Insulet Corporation
- Integrity Applications
- Intel Corporation
- International Technidyne
- Inverness Medical Innovations
- Knome
- Lab Express
- LifeAssays AB
- Lifescan
- LifeSign LLC
- LifeStat
- Lifestream Technologies, Inc.
- Lifestyle Choices
- Luminex
- Luminous Medical
- MACHEREY-NAGEL
- Masimo Corp
- Matritech
- M-Biotech
- Medical Automation Systems
- MedMira Inc.
- Medtronic Inc.
- Menssana Research, Inc.
- Meretek Diagnostics Inc.
- Meridian Bioscience
- Micromem Technologies
- Micronics Inc.
- MicroPhage, Inc.
- MinuteClinic
- Mitsubishi Kagaku Iatron
- MP Biomedicals
- Multilyte Limited
- MycroLab Pty
- Nanogen
- Nanomix, Inc.
- Nanosphere, Inc.
- National Jewish Health
- Navigenics, Inc.
- Network Biosystems
- Neuroptix Corp
- Nihon Kohden
- Noninvasive Medical Tech
- Nova Biomedical
- OPTI Medical Systems
- OraSure Technologies
- Orion Diagnostica
- OrSense Ltd.
- Ortho Clinical Diagnostics
- OvumOptics, Inc.
- Oxford Biosensors
- Oxonica Diagnostics
- Phadia AB
- Philips Handheld Immunoassays
- PlaCor, Inc.
- PointCare Technologies
- Polymedco
- Practice Fusion
- PreMD Inc.
- PrimeraDx
- Probe Scientific Ltd
- Prometheus Laboratories
- Psynomics
- QBC Diagnostics
- Qiagen
- Q-linea
- Quadraspec
- QualSec, Inc
- QuantRx Biomedical Corporation
- Quidel Corp
- Quotient Diagnostics
- Radiometer A/S
- Raman spectroscopy
- Rapid Pathogen Screening
- Rennesens GmbH
- Response Biomedical
- Rite Aid
- Roche Diagnostics
- Royal Philips Electronics
- Safeway, Inc.
- Screening Devices Canada
- SEMOFS
- Sentinel Bioactive Paper Network
- SeraCare Life Sciences
- Serotec
- Siemens Healthcare Diagnostics
- SIENCO
- Smiths Detection
- Smiths Medical MD
- Soar BioDynamics
- Solei Systems, Inc
- Solianis Monitoring
- SpectraScience, Inc.
- Sphere Medical Ltd.
- SpheroSense Technologies
- Stanbio Laboratory
- StatSure Diagnostic Systems
- STD Test Express
- STMicroelectronics
- Synova Healthcare
- Sysmex Corp
- T2 Biosystems
- Taidoc Technology
- TelCare
- Telus Corporation
- Textronics, Inc.
- Thermo Fisher Scientific
- Tosoh Corp
- Trinity Biotech
- TwistDx, Ltd.
- Tyrian Diagnostics
- UnitedHealth Group
- Veralight, Inc.
- Veredus Laboratories
- VeriChip Corporation
- Via Medical Corp
- Vital Diagnostics
- Vivacta Limited
- Walgreens
- Wal-Mart Stores
- Webahn Inc.
- Ypsomed
- CHAPTER ONE: EXECUTIVE SUMMARY
- Scope and Methodology
- Size and Growth of the Market
- Market Trends
- CHAPTER TWO: INTRODUCTION
- Miniaturization, Digitization and Informatics
- The pros and cons of POC testing
- Point of View
- CHAPTER THREE: ECONOMICS, EMR AND HEALTHCARE REFORM
- Healthcare Reform
- POC and Clinical Outcomes Management
- POC’s Unmet Need
- CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS
- Background
- The search for non-invasive tools
- Saliva
- Breath
- Optical Techniques
- Patch Technology
- Wearable Sensors/Textiles
- The Wireless Revolution
- Connectivity Imperative
- Lab-on-a chip
- CHAPTER FIVE: VENUES FOR POC TESTING
- POC Testing in the Hospital
- POL and Clinic Testing
- Retail Outlets
- Other Professional POC Venues - Workplace Testing and Home Visits
- Home Monitoring of Individuals with Chronic Diseases
- Self-Test Sector - OTC Tests
- CHAPTER SIX: MARKET ANALYSIS
- Market Overview
- Prognosis for POC growth
- Technological Challenges
- Market and Forecasts
- Self Testing/OTC
- Breakout of Non-Glucose Tests
- Professional POC Testing
- POC in world markets
- Europe
- Asia
- Rest of World
- United States
- Physician Office Labs
- United Kingdom
- HIV/AID
- Market for Rapid Flu Testin
- The Major Players
- Licenses and Distribution Agreements
- Struggling Competitors
- CHAPTER SEVEN: POC TEST SEGMENTS
- Diabetes Testing - Blood Glucose Monitoring (BGM)
- Blood Glucose Self-Testing
- Blood Glucose Testing by Professionals
- Diabetes Testing - Glycated Hemoglobin
- Cardiovascular Diagnostics
- Cardiac Markers (AMI enzymes)
- Cholesterol/Lipid Panels
- Clinical Chemistry/Critical Care
- Hemoglobin Testing for Anemia
- Hematology
- Coagulation
- Decentralized Coagulation testing - Professional Use
- Decentralized Coagulation Testing - OTC
- Drugs of Abuse/Therapeutic Drug Monitoring
- Allergy
- Infectious Diseases
- OTC Tests for Infectious Diseases
- Professional POC Tests for Infectious Diseases
- Pharmacodiagnostics
- Sepsis
- Oncology
- Bladder Cancer
- Colon Cancer
- Prostate Cancer
- Cervical Cancer
- Women’s Health / Pregnancy/Fertility
- Emerging Tests and Technologies
- Commercial Outlook
- CHAPTER EIGHT: COMPANY PROFILES MAJOR COMPANIES
- Abbott Diagnostics
- Diabetes
- Critical Care
- Hematology
- ARKRAY, Inc.
- Distribution News
- Product News
- Bayer Diabetes Care
- Beckman Coulter Inc.
- Becton, Dickinson and Company (BD)
- bioMerieux Inc.
- Bio-Rad Laboratories Inc.
- GE Healthcare
- Instrumentation Laboratory
- Inverness Medical Innovations
- Lifescan Inc.
- Nova Biomedical
- Ortho Clinical Diagnostics (OCD)
- Qiagen N.V.
- Quidel Corporation
- Radiometer A/S
- Roche Diagnostics
- Diabetes
- Cardiac Markers
- Clinical Chemistry
- Critical Care
- Siemens Healthcare Diagnostics
- Cardiac Markers
- Diabetes Care
- Blood Gases
- Urinalysis
- Sysmex Corporation
- TOSOH Corporation
- ‘New Frontier’ POC COMPANIES
- 3M Health Care
- 77 Elektronika Kft.
- Abaxis, Inc.
- A/C Diagnostics
- Accumetrics
- ACIST Medical Systems, Inc.
- AgaMetrix, Inc.
- Alfa Wassermann Diagnostic Technologies, LLC (AWDT)
- American Bio Medica Corp
- Audit Diagnostics
- Axis-Shield plc
- Biohit Oy
- BioIQ
- Biomerica, Inc.
- Biosite Incorporated
- B.R.A.H.M.S. AG
- Calypte Biomedical Corporation
- Chembio Diagnostic Systems, Inc.
- Chempaq A/S
- Cholestech Corporation
- Concateno plc
- DexCom, Inc.
- Diabetech, LP
- Diazyme Laboratories
- EKF-diagnostic GmbH
- ESA Biosciences Inc.
- Hain Lifescience GmbH
- HandyLab, Inc.
- Helena Laboratories USA
- Hema Diagnostic Systems (HDS)
- HemoCue AB
- HemoSense, Inc.
- Home Diagnostics, Inc.
- Horiba ABX S.A.
- Insulet Corporation
- International Technidyne Corp (ITC)
- Masimo Corporation
- Matritech
- Medical Automation Systems, Inc.
- MedMira Inc.
- Medtronic Inc.
- A. Menarini Diagnostics
- Meridian Bioscience
- MP Biomedicals LLC
- Nanosphere, Inc.
- OPTI Medical Systems, Inc.
- OraSure Technologies, Inc.
- Phadia AB
- Philips Handheld Immunoassays
- Polymedco, Inc.
- QBC Diagnostics, Inc.
- Response Biomedical Corp
- Serotec (AbD Serot
- Smiths Medical MD, Inc. (formerly Deltec, Inc.)
- Stanbio Laboratory
- Taidoc Technology Corp.
- Trinity Biotech plc
- Via Medical Corporation
- Vital Diagnostics
- Other Players
- Acrongenomics Inc.
- Alfa Scientific Designs, Inc.
- Amic AB
- Astron Clinica
- AspenBio Pharma, Inc.
- AT First Diagnostic, LLC
- bioLytical Laboratories Inc.
- Biomagnetics Diagnostics Corporation
- Bionime Corporation
- BodyTel Scientific, Inc.
- Burnet Institute
- Celerus Diagnostics
- Chelsea Technologies Group Ltd
- Claros Diagnostics
- CLX Medical, Inc.
- ContraVac, Inc.
- Decision Biomarkers Inc.
- Diabetes Sentry Products Inc.
- Diaglobal GmbH
- Diagnostic Devices, Inc.
- Diagnostics for All (DFA)
- Diagnostics for the Real World (DRW)
- Digital Bio Technology/ InCyto
- Diversa Limited (formerly Ambri Ltd.)
- DNAFORM
- DxNA
- Echo Therapeutics, Inc. (previously Sontra Medical)
- Enigma Diagnostics Limited
- Enterix Inc.
- Entra Health Systems
- Epocal, Inc.
- EUMED Biotechnology Co. Ltd.
- eScreen, Inc.
- EyeMarker Systems, Inc.
- Flexsite Diagnostics, Inc.
- Fora Care
- GenBio
- Gene Smart Wellness
- Gentag Inc.
- Glucometrics, Inc.
- Guided Therapeutics, Inc.
- Hai Kang Life Corporation
- HealthPia America
- Heidelberger-Medical-Marketing GmbH (HMM GmbH)
- Hema Metrics
- Hoana Medical, Inc.
- Idaho Technology, Inc.
- Identa Corporation
- Identigene
- Innovative Biosensors, Inc.
- Integrity Applications Ltd.
- Intel Corporation
- LifeAssays AB
- LifeSign LLC
- Lifestyle Choices Ltd
- Luminous Medical, Inc.:
- M-Biotech
- Menssana Research, Inc.
- Micromem Technologies Inc.
- Micronics Inc.
- MicroPhage, Inc.
- Multilyte Limited
- MycroLab Pty Ltd.
- Nanomix, Inc.
- National Jewish Health
- Network Biosystems
- Neuroptix Corporation
- Noninvasive Medical Technologies, Inc.
- OrSense Ltd.
- OvumOptics, Inc.
- Oxonica Diagnostics
- PlaCor, Inc.
- PointCare Technologies
- Probe Scientific Ltd
- Prometheus Laboratories Inc.
- Q-linea
- Quadraspec
- QualSec, Inc
- QuantRx Biomedical Corporation
- Quotient Diagnostics
- Rapid Pathogen Screening
- Rennesens GmbH
- Screening Devices Canada, Inc.
- Sentinel Bioactive Paper Network
- Sphere Medical Ltd.
- SIENCO
- Smiths Detection
- Solei Systems, Inc.
- Solianis Monitoring AG
- SpheroSense Technologies Inc.
- STD Test Express
- Surface Enhanced Micro Optical Fluidic Systems
- T2 Biosystems, Inc.
- TwistDx, Ltd.
- Veralight, Inc.
- Veredus Laboratories Pte
- VeriChip Corporation
- Vivacta Limited
- LIST OF EXHIBITS
- CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Exchange Rate Fluctuations, 2005-2008
- Table 1-2: POC Sales by Test Category (OTC and POC), Worldwide 2008-2013
- CHAPTER FOUR: TECHNOLOGY AND INDUSTRY TRENDS
- Table 4-1: Selected Non-Invasive Testing Innovations
- Table 4-2: Selected disease markers in exhaled breath
- Table 4-3: Selected POC Wireless Innovations, 2008-2009
- Table 4-4: RALS connected POC systems, 2009
- Table 4-5: Selected biochip and biosensor innovations, 2009
- CHAPTER FIVE: VENUES FOR POC TESTING
- Figure 5-1: Venues for POC Testing (Hospital, Physician, Other)
- Table 5-1: POC Test Sales in the Hospital Sector (Critical Care, Glucose, Cardiac Markers, Infectious Diseases, Coagulation, Hematology, Drugs of Abuse, Cholesterol, Pregnancy, Urinalysis), 2008
- Table 5-2: POC Test Sales in the POL Sector (Glucose, Cholesterol, HbA1c, Coagulation, Hematology, Chemistry/Immunoassays, Infectious Diseases, Fecal Occult Blood, Pregnancy, Cardiac Markers, Oncology, Urinalysis, Drugs of Abuse), 2008
- Table 5-3: Selected Small Footprint Chemistry Systems, 2009
- Table 5-4: Selected Small Footprint Hematology Systems, 2009
- Table 5-5: Selected New Small Footprint Immunoassay Systems, 2009
- Table 5-6: POC Test Sales in Other Care Venues (Glucose, Cholesterol, Drugs of Abuse, Fecal Occult Blood, Infectious Diseases, Urinalysis, Coagulation), 2008
- Table 5-7: Selected self-test innovations, 2008-2009
- CHAPTER SIX: MARKET ANALYSIS
- Table 6-1: OTC/Self Test Sales by Test Category (Glucose, Pregnancy, Coagulation, Fecal Occult Blood, Drugs of Abuse, HbA1c, HIV, Cholesterol, Other) Worldwide 2008 and 2013
- Figure 6-1: Breakout of Non-Glucose Self-Testing
- Figure 6-2: Professional POC Testing Market by Test Category
- Table 6-2: Professional Point of Care Testing Market by Test Category (Glucose, Critical Care, Cardiac Markers, Infectious Diseases, Cholesterol/Lipids, Coagulation, Hematology, HbA1c, Chemistry/Immunoassays, Fecal Occult Blood, Drugs of Abuse, Pregnancy, Urinalysis, Onocology, Other) 2008 and 2013
- Figure 6-3: Professional POC Testing Market by Test Category
- Table 6-3: POC Test Sales by Region (US, Europe, Asia, ROW), 2008-2013
- Table 6-4: POC Test Revenues of Selected IVD Companies, $ million, estimated
- Table 6-5: Selected Market Expansion Deals in POC testing, 2008-2009
- CHAPTER SEVEN: POC TEST SEGMENTS
- Table 7-1: World Glucose Monitoring Sales, by Company, 2005 - 2008
- Table 7-2: Selected Glucose Meter Innovations, 2008-2009
- Table 7-3: Selected Wireless Enabled Blood Glucose Monitors, 2009
- Table 7-4: Selected Continuous BGM Sales by Company, 2008
- Table 7-5: Selected Continuous Blood Glucose Systems, 2009
- Table 7-6: Glucose Meters that use GDH-PQQ technology
- Table 7-7: Selected POC HbA1c Devices, 2009
- Table 7-8: Worldwide Sales, POC CVD markers (Cholesterol -Professional, Cholesterol OTC, AMI Enzymes), 2008-2013
- Table 7-9: Selected POC Hematology Systems, 2009
- Table 7-10: World POC Coagulation Sales(PT-Professional, PT OTC, ACT), 2008 (million)
- Table 7-11: Selected CLIA Waived PT Devices
- Table 7-12: Selected Rapid HIV Tests on the Market
- Table 7-13: Selected Rapid Infectious Disease Test Innovations
- Table 7-14: Selected Women’s Health OTC Tests
- Table 7-15: Selected POC Platform Innovations, 2008/2009
